RNA polymerase II holoenzyme

RNA polymerase II holoenzyme is a form of eukaryotic RNA polymerase II that is recruited to the promoters of protein-coding genes in living cells.^[1][2] It consists of RNA polymerase II, a subset of general transcription factors, and regulatory proteins known as SRB proteins^{[clarification needed]}.

RNA polymerase II

RNA polymerase II (also called RNAP II and Pol II) is an enzyme found in

form homodimers).

General transcription factors

General transcription factors (GTFs) or basal transcription factors are

The cluster of RNA polymerase II and various transcription factors is known as a basal transcriptional complex (BTC).

Preinitiation complex

The preinitiation complex (PIC) is a large complex of

The typical PIC is made up of six general transcription factors:

.

The construction of the polymerase complex takes place on the

Assembly of the PIC

Although the sequence of steps involved in the assembly of the PIC can vary, in general, they follow step 1, binding to the

promoter

.

1. The
   TFIID can also be involved when the TATA box
   is absent. A TFIID TAF will bind sequence specifically, and force the TBP to bind non-sequence specifically, bringing the remaining portions of TFIID to the promoter.
2. TFIIA interacts with the TBP subunit of TFIID and aids in the binding of TBP to TATA-box
   containing promoter DNA. Although TFIIA does not recognize DNA itself, its interactions with TBP allow it to stabilize and facilitate formation of the PIC.
3. The
   TFIIB brings the DNA into proper position for entry into the active site of RNA polymerase II. TFIIB binds partially sequence specifically, with some preference for BRE. The TFIID-TFIIA-TFIIB (DAB)-promoter complex subsequently recruits RNA polymerase II and TFIIF.^[8]
4. TFIIF (two subunits, RAP30 and RAP74, showing some similarity to bacterial sigma factors) and Pol II
   enter the complex together. TFIIF helps to speed up the polymerization process.
5. TFIIE helps to open and close the Pol II
   ’s Jaw-like structure, which enables movement down the DNA strand.
6. promoter, forming the transcription bubble
   .
7. C-terminal domain (CTD) of Pol II at the amino acid serine. This switches the RNA polymerase to start producing RNA.^[9] Finally it is essential for Nucleotide Excision Repair
   (NER) of damaged DNA. TFIIH and TFIIE strongly interact with one another. TFIIE affects TFIIH's catalytic activity. Without TFIIE, TFIIH will not unwind the promoter.
8. denatured or if it is supercoiled
   .
9. Mediator then encases all the transcription factors and Pol II. It interacts with enhancers, areas very far away (upstream or downstream) that help regulate transcription.^[10]

The formation of the preinitiation complex (PIC) is analogous to the mechanism seen in bacterial initiation. In bacteria, the sigma factor recognizes and binds to the promoter sequence. In eukaryotes, the transcription factors perform this role.^[9]

Mediator complex

Mediator is a multiprotein complex that functions as a transcriptional

It works in the same manner in mammals.

The mediator functions as a coactivator and binds to the

C-terminal domain (CTD)

The carboxy-terminal domain (CTD) of RNA polymerase II is that portion of the polymerase that is involved in the initiation of

The CTD is an extension appended to the C terminus of RPB1, the largest subunit of RNA polymerase II. It serves as a flexible binding scaffold for numerous nuclear factors, determined by the phosphorylation patterns on the CTD repeats. Each repeat contains an evolutionary conserved and repeated heptapeptide, Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7, which is subjected to reversible phosphorylations during each transcription cycle.^[16] This domain is inherently unstructured yet evolutionarily conserved, and in eukaryotes it comprises from 25 to 52 tandem copies of the consensus repeat heptad.^[15] As the CTD is frequently not required for general transcription factor (GTF)-mediated initiation and RNA synthesis, it does not form a part of the catalytic essence of RNAPII, but performs other functions.^[16]

CTD phosphorylation

RNAPII can exist in two forms: RNAPII0, with a highly phosphorylated CTD, and RNAPIIA, with a nonphosphorylated CTD.

Ser5 phosphorylation (Ser5PO₄) near the 5′ ends of genes depends principally on the kinase activity of

CDK9

kinase in metazoans). Ctk1 (CDK9) acts in complement to phosphorylation of serine 5 and is, thus, seen in middle to late elongation.

The gene

Also involved in the phosphorylation and regulation of the RPB1 CTD is cyclin T1 (

and regulation.

CDK9

EC 2.7.11.23.

TFIIB

). The large subunit of TFIIF (RAP74) stimulates the CTD phosphatase activity, whereas TFIIB inhibits TFIIF-mediated stimulation. Dephosphorylation of the CTD alters the migration of the largest subunit of RNAPII (RPB1).

5' capping

The carboxy-terminal domain is also the binding site of the cap-synthesizing and cap-binding complex. In eukaryotes, after transcription of the 5' end of an RNA transcript, the cap-synthesizing complex on the CTD will remove the gamma-phosphate from the 5'-phosphate and attach a GMP, forming a 5',5'-triphosphate linkage. The synthesizing complex falls off and the cap then binds to the cap-binding complex (CBC), which is bound to the CTD.

The 5'cap of eukaryotic RNA transcripts is important for binding of the mRNA transcript to the ribosome during translation, to the CTD of RNAP, and prevents RNA degradation.

Spliceosome

The carboxy-terminal domain is also the binding site for spliceosome factors that are part of RNA splicing. These allow for the splicing and removal of introns (in the form of a lariat structure) during RNA transcription.

Mutation in the CTD

Major studies in which knockout of particular

was achieved in the CTD have been carried out. The results indicate that RNA polymerase II CTD truncation mutations affect the ability to induce transcription of a subset of genes in vivo, and the lack of response to induction maps to the upstream activating sequences of these genes.

Genome surveillance complex

Several protein members of the BRCA1-associated genome surveillance complex (BASC) associate with RNA polymerase II and play a role in transcription.^[21]

The transcription factor

.

The

), a subunit of the RNA polymerase II transcription factor IIH, and ERCC6. It is involved in transcription-coupled excision repair.

Higher error ratios in transcription by RNA polymerase II are observed in the presence of Mn²⁺ compared to Mg²⁺.[23]

Transcription coactivators

The EDF1 gene encodes a protein that acts as a transcriptional coactivator by interconnecting the general transcription factor TATA element-binding protein (TBP) and gene-specific activators.^[24]

) complexes (mediator complex, plus THRAP3 protein) assemble cooperatively on promoter DNA, from which they become part of the RNAPII holoenzyme.

Transcription initiation

The completed assembly of the holoenzyme with transcription factors and RNA polymerase II bound to the promoter forms the eukaryotic transcription initiation complex. Transcription in the archaea domain is similar to transcription in eukaryotes.^[25]

Transcription begins with matching of NTPs to the first and second in the DNA sequence. This, like most of the remainder of transcription, is an energy-dependent process, consuming adenosine triphosphate (ATP) or other NTP.

Promoter clearance

After the first bond is synthesized, the RNA polymerase must clear the promoter. During this time, there is a tendency to release the RNA transcript and produce truncated transcripts. This is called abortive initiation and is common for both eukaryotes and prokaryotes.^[26] Abortive initiation continues to occur until the σ factor rearranges, resulting in the transcription elongation complex (which gives a 35 bp-moving footprint). The σ factor is released before 80 nucleotides of mRNA are synthesized.^[27] Once the transcript reaches approximately 23 nucleotides, it no longer slips and elongation can occur.

Initiation regulation

Due to the range of genes that Pol II transcribes, this is the polymerase that experiences the most regulation by a range of factors at each stage of transcription. It is also one of the most complex in terms of polymerase cofactors involved.

Initiation is regulated by many mechanisms. These can be separated into two main categories:

1. Protein interference.
2. Regulation by phosphorylation.

Regulation by protein interference

Protein interference is the process where in some signaling protein interacts, either with the promoter or with some stage of the partially constructed complex, to prevent further construction of the polymerase complex, so preventing initiation. In general, this is a very rapid response and is used for fine level, individual gene control and for 'cascade' processes for a group of genes useful under a specific conditions (for example, DNA repair genes or heat shock genes).

Chromatin structure inhibition is the process wherein the promoter is hidden by chromatin structure. Chromatin structure is controlled by post-translational modification of the histones involved and leads to gross levels of high or low transcription levels. See: chromatin, histone, and nucleosome.

These methods of control can be combined in a modular method, allowing very high specificity in transcription initiation control.

Regulation by phosphorylation

The largest subunit of Pol II (Rpb1) has a domain at its C-terminus called the CTD (C-terminal domain). This is the target of

.

The CTD consists of repetitions of an

. The number of these repeats varies; the mammalian protein contains 52, while the yeast protein contains 26. Site-directed-mutagenesis of the yeast protein has found at least 10 repeats are needed for viability. There are many different combinations of phosphorylations possible on these repeats and these can change rapidly during transcription. The regulation of these phosphorylations and the consequences for the association of transcription factors plays a major role in the regulation of transcription.

During the transcription cycle, the CTD of the large subunit of RNAP II is reversibly phosphorylated. RNAP II containing unphosphorylated CTD is recruited to the promoter, whereas the hyperphosphorylated CTD form is involved in active transcription. Phosphorylation occurs at two sites within the heptapeptide repeat, at Serine 5 and Serine 2. Serine 5 phosphorylation is confined to promoter regions and is necessary for the initiation of transcription, whereas Serine 2 phosphorylation is important for mRNA elongation and 3'-end processing.

Elongation

The process of elongation is the synthesis of a copy of the DNA into messenger RNA. RNA Pol II matches complementary RNA nucleotides to the template DNA by Watson-Crick base pairing. These RNA nucleotides are ligated, resulting in a strand of messenger RNA.

Unlike DNA replication, mRNA transcription can involve multiple RNA polymerases on a single DNA template and multiple rounds of transcription (amplification of particular mRNA), so many mRNA molecules can be rapidly produced from a single copy of a gene.

Elongation also involves a proofreading mechanism that can replace incorrectly incorporated bases. In eukaryotes, this may correspond with short pauses during transcription that allow appropriate RNA editing factors to bind. These pauses may be intrinsic to the RNA polymerase or due to chromatin structure.

Elongation regulation

RNA Pol II elongation promoters can be summarised in three classes:

1. Drug/sequence-dependent arrest affected factors, e.g., SII (TFIIS) and P-TEFb protein families.
2. Chromatin structure oriented factors. Based on histone post translational modifications – phosphorylation, acetylation, methylation and ubiquination.

   See: chromatin, histone, and nucleosome

3. RNA Pol II catalysis improving factors. Improve the Vmax or Km of RNA Pol II, so improving the catalytic quality of the polymerase enzyme. E.g. TFIIF, Elongin and ELL families.

   See:

   Michaelis constant, and Lineweaver–Burk plot

As for initiation, protein interference, seen as the "drug/sequence-dependent arrest affected factors" and "RNA Pol II catalysis improving factors" provide a very rapid response and is used for fine level individual gene control. Elongation downregulation is also possible, in this case usually by blocking polymerase progress or by deactivating the polymerase.

Chromatin structure-oriented factors are more complex than for initiation control. Often the chromatin-altering factor becomes bound to the polymerase complex, altering the histones as they are encountered and providing a semi-permanent 'memory' of previous promotion and transcription.

Termination

Termination is the process of breaking up the polymerase complex and ending the RNA strand. In

using RNA Pol II, this termination is very variable (up to 2000 bases), relying on post transcriptional modification.

Little regulation occurs at termination, although it has been proposed newly transcribed RNA is held in place if proper termination is inhibited, allowing very fast expression of genes given a stimulus. This has not yet been demonstrated in

.

Transcription factory

Active RNA Pol II transcription holoenzymes can be clustered in the nucleus, in discrete sites called

The intranuclear position of many genes is correlated with their activity state. During transcription in vivo, distal active genes are dynamically organized into shared nuclear subcompartments and colocalize to the same transcription factory at high frequencies.[28] Movement into or out of these factories results in activation (On) or abatement (Off) of transcription, rather than by recruiting and assembling a transcription complex.^[28] Usually, genes migrate to preassembled factories for transcription.^[28]

An expressed

chromosome territory, but a closely linked, inactive gene is located inside.^[30]

Holoenzyme stability

RNA polymerase II holoenzyme stability determines the number of base pairs that can be transcribed before the holoenzyme loses its ability to transcribe. The length of the CTD is essential for RNA polymerase II stability.[31] RNA polymerase II stability has been shown to be regulated by post-translation proline hydroxylation.^[32] The von Hippel–Lindau tumor suppressor protein (pVHL, human GeneID: 7428^[33]) complex binds the hyperphosphorylated large subunit of the RNA polymerase II complex, in a proline hydroxylation- and CTD phosphorylation-dependent manner, targeting it for ubiquitination.^[32]

See also

• RNA polymerase I
• RNA polymerase III
• Post-transcriptional modification
• Transcription (genetics)
• Eukaryotic transcription

References

1. S2CID 4309666
   .
2. PMID 9774381
   .
3. PMID 10611681
   .
4. PMID 15145350.{{cite journal}}: CS1 maint: numeric names: authors list (link
   )
5. ^
   PMID 11092823
   .
6. PMID 8946909
   .
7. ^ "Polymerase II". Archived from the original on 2004-10-18.
8. ^
   PMID 9891058
   .
9. ^
   ISBN 978-0-7167-7928-5
   .
10. PMID 12482986. Archived from the original
    (PDF) on 2011-07-13.
11. PMID 16168358
    .
12. PMID 15896741
    .
13. PMID 7498740
    .
14. S2CID 4418258
    .
15. ^
    PMID 2251729
    .
16. ^
    PMID 17079683
    .
17. ^ "CDK8 cyclin-dependent kinase 8 [Homo sapiens]".
18. ^ "CTDP1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 [ Homo sapiens ]".
19. ^ "CCNT1 cyclin T1 [ Homo sapiens ]". {{cite web}}: Missing or empty |url= (help)
20. PMID 10385623
    .
21. ^ "BRCA1 breast cancer 1, early onset [ Homo sapiens ]".
22. S2CID 21846012
    .
23. ISBN 978-3-540-71525-2
    .
24. ^ "EDF1 endothelial differentiation-related factor 1 [ Homo sapiens ]".
25. PMID 12692306
    .
26. PMID 19443781
    .
27. PMID 12213653
    .
28. ^
    PMID 15361872
    .
29. PMID 12975345
    .
30. PMID 15155579
    .
31. PMID 19449052
    .
32. ^
    PMID 12604794
    .
33. ^ "VHL von Hippel-Lindau tumor suppressor [ Homo sapiens ]".

• Liao S, Zhang J, Jeffery DA, et al. (2002). "A kinase–cyclin pair in the RNA polymerase II holoenzyme". Nature. 374 (6518): 193–6.
  S2CID 2238903
  .
• RNA Polymerase: Components of the Transcription Initiation Machinery
• Neish AS, Anderson SF, Schlegel BP, Wei W, Parvin JD (February 1998). "Factors associated with the mammalian RNA polymerase II holoenzyme". Nucleic Acids Res. 26 (3): 847–53.
  PMID 9443979
  .
• Thompson CM, Young RA (May 1995). "General requirement for RNA polymerase II holoenzymes in vivo". Proc. Natl. Acad. Sci. U.S.A. 92 (10): 4587–90.
  PMID 7753848
  .

External links

• More information at Berkeley National Lab
• RNA+Polymerase+II at the U.S. National Library of Medicine Medical Subject Headings (MeSH)